Athersys
Athersys is to Initiate a Pivotal Clinical Trial Evaluating MultiStem® Cell Therapy in Patients With COVID-19 Induced Acute Respiratory Distress Syndrome
Rankings by
National Ranking393rd
in United States Regional Ranking447th
in North America and Caribbean Global Ranking1062nd
worldwide